VEGF/VEGFR轴及其在黑色素瘤中的信号:对治疗向剂的当前知识和未来的前景
Mohammad Malekan1, Nikolas K Haass2, Ghasem Rahmatpour Rokni3
1Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Life sciences
|March 20, 2024
概括
VEGF/VEGFR轴在黑色素瘤进展中至关重要,影响瘤生长和转移. 针对这一轴,为黑色素瘤治疗提供了有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 黑色素瘤是一种致命的皮肤癌,由复杂的致病过程驱动.
- 血管内皮生长因子 (VEGF) /VEGF受体 (VEGFR) 轴在黑色素瘤血管生成和进展中发挥着关键作用.
研究的目的:
- 审查VEGF/VEGFR轴在黑色素瘤中的多方面的作用.
- 探索其作为诊断/预后生物标志物和治疗点的潜力.
主要方法:
- 对调查黑色素瘤中VEGF/VEGFR轴的研究进行文献综述.
- 对信号通路 (MAPK/ERK,PI3K/AKT等) 的分析. 通过VEGF/VEGFR进行调节.
- 检查与VEGF/VEGFR轴相关的微RNA.
主要成果:
- VEGF/VEGFR轴信号影响黑色素瘤细胞的生长,增殖,迁移,转移,存活和治疗耐药性.
- 过度表达VEGF与预后不佳,侵袭性增加和治疗响应减少有关.
- 微RNA可以通过VEGF/VEGFR轴促进或限制黑色素瘤血管生成.
结论:
- VEGF/VEGFR轴是黑色素瘤发病的一个重要因素,也是一个可行的治疗点.
- 向剂,包括抗VEGF和VEGFR抑制剂,是与现代疗法相辅相成的关键策略.
- 进一步研究VEGF/VEGFR轴和相关的微RNA可以改善黑色素瘤的治疗.
关键词:
血管新生的产生.生物标志物 生物标志物黑色素瘤是一种黑色素瘤.微RNAs是一种微RNA.信号通道的信号通道.有针对性的治疗.在VEGF中,VEGF是VEGF.在VEGFR中,VEGFR是VEGFR.更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
2.9K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
